Page last updated: 2024-11-05

trihexyphenidyl and Actinic Reticuloid Syndrome

trihexyphenidyl has been researched along with Actinic Reticuloid Syndrome in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HAYS, GB1
LYLE, CB1
WHEELER, CE1

Other Studies

1 other study available for trihexyphenidyl and Actinic Reticuloid Syndrome

ArticleYear
SLATE-GRAY COLOR IN PATIENTS RECEIVING CHLORPROMAZINE.
    Archives of dermatology, 1964, Volume: 90

    Topics: Argyria; Chlorpromazine; Chromatophores; Dermatitis, Phototoxic; Diagnosis, Differential; Drug Thera

1964